In the BioHarmony Drug Report Database

"Preview" Icon

Tazobactam

Zosyn, Zerbaxa (tazobactam) is a small molecule pharmaceutical. Tazobactam was first approved as Zosyn on 1993-10-22. It has been approved in Europe to treat bacterial infections. Zosyn in galaxy containers’s patent is valid until 2023-04-14 (FDA).

 

Trade Name

 

Zerbaxa
 

Common Name

 

tazobactam
 

ChEMBL ID

 

CHEMBL404
 

Indication

 

bacterial infections
 

Drug Class

 

Beta-lactamase inhibitors

Image (chem structure or protein)

Tazobactam structure rendering